Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Numbing sprays ease dialysis needle pain, study finds

NCT ID NCT07242157

Symptom relief Sponsor: TC Erciyes University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether lidocaine or benzocaine sprays could reduce pain and improve satisfaction during needle insertion for hemodialysis. 60 patients were randomly assigned to receive one of the two numbing sprays or a placebo. The goal was to see if these sprays make the procedure more comfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

60 people

The number who actually took part.

Started

Apr 2024

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged ≥18 years, * non-pregnant, not planning pregnancy, * receiving hemodialysis three times weekly for at least three months, * continuously treated at the same institution without any change in treatment regimen, * without pain in any part of the body affecting study outcomes, * with a Visual Analog Scale (VAS) pain score of zero at baseline, * no analgesics within 24 hours prior, * a baseline Algometer pressure pain threshold of 8-16 lbs. * participants were required to understand Turkish, * communicate effectively, * volunteer for the study, and * provide written informed consent. Exclusion Criteria: * Individuals with neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, or multiple sclerosis, * unable or unwilling to comply with study protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arteriovenous fistula are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congenital arteriovenous fistula end stage renal failure Pain Personal Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arteriovenous fistula Hemodialysis Pain Satisfaction

Contacts and locations

Locations

  • Erciyes Universty

    Kayseri, Talas, 38039, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.